2:
Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region.
Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, Dwyer R, McCormack G, Hellard M, Cherry C, McArthur J, Wesselingh S.
Neurology. 2008 Jul 1;71(1):50-6.
PMID: 18591505 [PubMed - indexed for MEDLINE]
Related Articles
4:
A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis.
Villamor E, Mugusi F, Urassa W, Bosch RJ, Saathoff E, Matsumoto K, Meydani SN, Fawzi WW.
J Infect Dis. 2008 Jun 1;197(11):1499-505.
PMID: 18471061 [PubMed - indexed for MEDLINE]
Related Articles
5:
Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.
Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenal B, Lai AR, Saghayam S, Balakrishnan P, Yepthomi T, Poongulali S, Flanigan TP, Solomon S, Mayer KH.
AIDS Patient Care STDS. 2008 Apr;22(4):337-44.
PMID: 18422462 [PubMed - indexed for MEDLINE]
Related Articles
7:
Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal.
Canestri A, Sow PS, Vray M, Ngom F, M'boup S, Kane CT, Delaporte E, Gueye M, Peytavin G, Girard PM, Landman R; ANRS 12-06/IMEA 012 Trial Study Group.
MedGenMed. 2007 Oct 9;9(4):7.
PMID: 18311357 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
9:
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.
Hoffmann CJ, Fielding KL, Charalambous S, Sulkowski MS, Innes C, Thio CL, Chaisson RE, Churchyard GJ, Grant AD.
AIDS. 2008 Jan 2;22(1):67-74.
PMID: 18090393 [PubMed - indexed for MEDLINE]
Related Articles
10:
Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial.
Wester CW, Okezie OA, Thomas AM, Bussmann H, Moyo S, Muzenda T, Makhema J, van Widenfelt E, Musonda R, Novitsky V, Gaolathe T, Ndwapi N, Essex M, Kuritzkes DR, DeGruttola V, Marlink RG.
J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):318-22.
PMID: 18090299 [PubMed - indexed for MEDLINE]
Related Articles
11:
Unhealthy behaviours for self-management of HIV-related peripheral neuropathy.
Nicholas PK, Voss JG, Corless IB, Lindgren TG, Wantland DJ, Kemppainen JK, Canaval GE, Sefcik EF, Nokes KM, Bain CA, Kirksey KM, Eller LS, Dole PJ, Hamilton MJ, Coleman CL, Holzemer WL, Reynolds NR, Portillo CJ, Bunch EH, Tsai YF, Mendez MR, Davis SM, Gallagher DM.
AIDS Care. 2007 Nov;19(10):1266-73.
PMID: 18071970 [PubMed - indexed for MEDLINE]
Related Articles
18:
Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.
Boulle A, Orrel C, Kaplan R, Van Cutsem G, McNally M, Hilderbrand K, Myer L, Egger M, Coetzee D, Maartens G, Wood R; International Epidemiological Databases to Evaluate Aids in Southern Africa Collaboration.
Antivir Ther. 2007;12(5):753-60.
PMID: 17713158 [PubMed - indexed for MEDLINE]
Related Articles